Overview

Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization

Status:
Unknown status

Trial end date:
2019-12-31

Target enrollment:

Participant gender:

Summary

In a double-blinded randomized clinical trial, all patients undergoing coronary artery catheterization who will met our criteria, will be enrolled into three groups to receive either, vitamin e, n-acetylcysteine, or placebo. The aim of study will be to compare the superiority of vitamin e over n-acetylcysteine for the prevention of contrast-induced acute kidney injury (CIAKI).

Phase:

Phase 3

Details

Lead Sponsor:

Rajaie Cardiovascular Medical and Research Center

Treatments:

Acetylcysteine
alpha-Tocopherol
N-monoacetylcystine
Tocopherols
Tocotrienols
Vitamin E
Vitamins